Florida Cancer Specialists - Lake Nona - Sarah Cannon Research Institute — Orlando, Florida

Florida Cancer Specialists - Lake Nona - Sarah Cannon Research Institute is a clinical research site located in Orlando, Florida, United States 32827.

Crixeo Health Trust Score: 63/100 (FAIR). This profile has not yet been claimed by the site owner.

Florida Cancer Specialists - Lake Nona - Sarah Cannon Research Institute has participated in 2 clinical trials with 2 currently active.

Therapeutic areas: Pancreatic Ductal Adenocarcinoma, Non-small Cell Lung Cancer, Colorectal Cancer.

Sponsors: Eli Lilly and Company.

Sponsor Feasibility Report

Trust Score: 63/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Florida Cancer Specialists - Lake Nona - Sarah Cannon Research Institute?

Florida Cancer Specialists - Lake Nona - Sarah Cannon Research Institute has a Crixeo Trust Score of 63/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Florida Cancer Specialists - Lake Nona - Sarah Cannon Research Institute conducted?

Florida Cancer Specialists - Lake Nona - Sarah Cannon Research Institute has 2 clinical trials on record, with 2 currently active. Their work covers Pancreatic Ductal Adenocarcinoma, Non-small Cell Lung Cancer, Colorectal Cancer.

Is Florida Cancer Specialists - Lake Nona - Sarah Cannon Research Institute accredited by Crixeo Health?

Florida Cancer Specialists - Lake Nona - Sarah Cannon Research Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Florida Cancer Specialists - Lake Nona - Sarah Cannon Research Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.